KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Goodwill (2016 - 2026)

Johnson & Johnson's Goodwill history spans 18 years, with the latest figure at $48.6 billion for Q1 2026.

  • On a quarterly basis, Goodwill rose 9.2% to $48.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $48.6 billion, a 9.2% increase, with the full-year FY2025 number at $48.8 billion, up 10.34% from a year prior.
  • Goodwill hit $48.6 billion in Q1 2026 for Johnson & Johnson, roughly flat from $48.8 billion in the prior quarter.
  • Over the last five years, Goodwill for JNJ hit a ceiling of $48.8 billion in Q4 2025 and a floor of $25.4 billion in Q1 2022.
  • Historically, Goodwill has averaged $40.9 billion across 5 years, with a median of $44.2 billion in 2024.
  • The widest YoY moves for Goodwill: up 17367.5% in 2022, down 30.11% in 2022.
  • Tracing JNJ's Goodwill over 5 years: stood at $33.4 billion in 2022, then rose by 9.51% to $36.6 billion in 2023, then grew by 20.9% to $44.2 billion in 2024, then grew by 10.34% to $48.8 billion in 2025, then dropped by 0.44% to $48.6 billion in 2026.
  • Business Quant data shows Goodwill for JNJ at $48.6 billion in Q1 2026, $48.8 billion in Q4 2025, and $48.0 billion in Q3 2025.